Gothenburg very early supported discharge study (GOTVED) NCT01622205: a block randomized trial with superiority design of very early supported discharge for patients with stroke.

MLA

Sunnerhagen, Katharina S., et al. “Gothenburg Very Early Supported Discharge Study (GOTVED) NCT01622205: A Block Randomized Trial with Superiority Design of Very Early Supported Discharge for Patients with Stroke.” BMC Neurology, vol. 13, June 2013, p. 66. EBSCOhost, https://doi.org/10.1186/1471-2377-13-66.

APA

Sunnerhagen, K. S., Danielsson, A., Rafsten, L., Björkdahl, A., Axelsson, Å. B., Nordin, Å., Petersson, C. A., Lundgren-Nilsson, Å., & Fröjd, K. (2013). Gothenburg very early supported discharge study (GOTVED) NCT01622205: a block randomized trial with superiority design of very early supported discharge for patients with stroke. BMC Neurology, 13, 66. https://doi.org/10.1186/1471-2377-13-66

Chicago

Sunnerhagen, Katharina S, Anna Danielsson, Lena Rafsten, Ann Björkdahl, Åsa B Axelsson, Åsa Nordin, Cathrine A Petersson, Åsa Lundgren-Nilsson, and Karin Fröjd. 2013. “Gothenburg Very Early Supported Discharge Study (GOTVED) NCT01622205: A Block Randomized Trial with Superiority Design of Very Early Supported Discharge for Patients with Stroke.” BMC Neurology 13 (June): 66. doi:10.1186/1471-2377-13-66.